Activities, Bill Numbers and Titles
|
H3367 - An Act relative to the substitution of interchangeable biosimilars
|
Neutral
|
none
| Eisai Inc. |
$265.00
|
H 2646 - An Act to eliminate the tax deduction for direct to consumer pharmaceutical marketing
|
Oppose
|
none
| Eisai Inc. |
$424.00
|
S 986 - An Act to protect patients from breakthrough seizures
|
Support
|
none
| Eisai Inc. |
$742.00
|
| | | Total amount |
$1,431.00
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
12/03/2013 |
The Keenan Committee
|
State Senate, Quincy district
|
$100.00
|
12/16/2013 |
The Baker Committee
|
Gubernatorial
|
$100.00
|
| | Total contributions |
$200.00
|
|